259 related articles for article (PubMed ID: 23874851)
1. The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.
Egecioglu E; Engel JA; Jerlhag E
PLoS One; 2013; 8(7):e69010. PubMed ID: 23874851
[TBL] [Abstract][Full Text] [Related]
2. The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice.
Egecioglu E; Engel JA; Jerlhag E
PLoS One; 2013; 8(10):e77284. PubMed ID: 24204788
[TBL] [Abstract][Full Text] [Related]
3. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
[TBL] [Abstract][Full Text] [Related]
4. The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents.
Egecioglu E; Steensland P; Fredriksson I; Feltmann K; Engel JA; Jerlhag E
Psychoneuroendocrinology; 2013 Aug; 38(8):1259-70. PubMed ID: 23219472
[TBL] [Abstract][Full Text] [Related]
5. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents.
Vallöf D; Kalafateli AL; Jerlhag E
Psychoneuroendocrinology; 2019 May; 103():284-295. PubMed ID: 30771711
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4 decreases amphetamine-induced locomotor activity.
Erreger K; Davis AR; Poe AM; Greig NH; Stanwood GD; Galli A
Physiol Behav; 2012 Jun; 106(4):574-8. PubMed ID: 22465309
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of intra-ventral tegmental area ghrelin and glucagon-like peptide-1 on the stimulatory action of D-amphetamine and cocaine-induced ethanol intake in male Sprague Dawley rats.
Colvin KJ; Killen HS; Kanter MJ; Halperin MC; Engel L; Dickinson MB; Fimmel AI; Holland JG; Currie PJ
Behav Brain Res; 2022 Mar; 421():113726. PubMed ID: 34954300
[TBL] [Abstract][Full Text] [Related]
8. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.
Sørensen G; Reddy IA; Weikop P; Graham DL; Stanwood GD; Wortwein G; Galli A; Fink-Jensen A
Physiol Behav; 2015 Oct; 149():262-8. PubMed ID: 26072178
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents.
Vallöf D; Vestlund J; Jerlhag E
Neuropharmacology; 2019 May; 149():124-132. PubMed ID: 30772374
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.
Bornebusch AB; Fink-Jensen A; Wörtwein G; Seeley RJ; Thomsen M
eNeuro; 2019; 6(2):. PubMed ID: 31058214
[TBL] [Abstract][Full Text] [Related]
11. The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents.
Vallöf D; Maccioni P; Colombo G; Mandrapa M; Jörnulf JW; Egecioglu E; Engel JA; Jerlhag E
Addict Biol; 2016 Mar; 21(2):422-37. PubMed ID: 26303264
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.
McKay NJ; Kanoski SE; Hayes MR; Daniels D
Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1755-64. PubMed ID: 21975647
[TBL] [Abstract][Full Text] [Related]
13. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
14. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
[TBL] [Abstract][Full Text] [Related]
15. The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naïve male mice.
Vestlund J; Jerlhag E
Horm Behav; 2020 Aug; 124():104778. PubMed ID: 32450068
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
[TBL] [Abstract][Full Text] [Related]
17. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1.
Jerlhag E
Brain Res; 2020 Jan; 1727():146562. PubMed ID: 31759971
[TBL] [Abstract][Full Text] [Related]
18. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
Mul JD; Begg DP; Barrera JG; Li B; Matter EK; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
Am J Physiol Regul Integr Comp Physiol; 2013 Jul; 305(1):R68-77. PubMed ID: 23616105
[TBL] [Abstract][Full Text] [Related]
19. Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward.
Shirazi RH; Dickson SL; Skibicka KP
PLoS One; 2013; 8(4):e61965. PubMed ID: 23613987
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis.
Koehler JA; Baggio LL; Cao X; Abdulla T; Campbell JE; Secher T; Jelsing J; Larsen B; Drucker DJ
Diabetes; 2015 Mar; 64(3):1046-56. PubMed ID: 25277394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
